China Pharma Cash Flow - Quarterly (NYSEMKT:CPHI)

Add to My Stocks
$0.22 $0 (0%) CPHI stock closing price Sep 19, 2018 (Closing)

The financial analysis of CPHI requires an investor to check the cash flows for China Pharma. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about China Pharma profits and China Pharma debt. China Pharma saw a cash impact of $- from the buyback of CPHI shares. The cash flow statement helps in the China Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. China Pharma has a negative cash and cash equivalents change of $-0.09M.

View and download details of China Pharma cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-1.3M-0.29M-19.27M-5.45M-3.25M-0.96M-9.18M-5.75M-4M-1.55M
Depreciation Depletion Amortization Cash-Flow1.71M-3.29M2.44M1.62M-3.07M2.58M1.72M-
Net Increase (Decrease) in Assets Liabilities-0.84M-0.07M1M-0.3M-0.91M-0.22M3.64M3.58M2.51M3.14M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net--15.81M3.2M1.76M-5.35M1M--1.14M
Net Cash from (used by) Operating Activities
----0.09M-0.77M-2.89M1.42M-1.3M
Increase (Decrease) in Prop Plant And Equipment-0.03M--0.13M-0.06M-0.05M-0.02M-0.19M-0.08M-0.06M-0.03M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
-0.03M--0.13M-0.06M-0.05M-0.02M-0.19M-0.08M-0.06M-0.03M
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities-0.16M-0.15M-1.47M-1.46M-0.14M-0.14M-1.5M-1.51M-0.3M-0.3M
Increase (Decrease) in Bank & Other Borrowings-------4.51M-2.27M--
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
-0.16M-0.15M-1.47M-1.46M-0.14M-0.14M-6.02M-3.79M-0.3M-0.3M
Effect of Exchange Rate Changes on Cash-0.03M------0.26M-0.13M-0.14M-
Net Change in Cash & Cash Equivalents
-0.09M--0.63M-1.54M-0.92M-0.14M-3.58M-2.59M-1.01M
Cash & Equivalents at Beginning of Year2.03M2.66M6.24M5.29M5.99M4.02M4.05M3.69M3.63M6.92M
Cash & Equivalents at Year End1.94M2.46M2.03M1.12M1.74M2.52M2.66M3.65M6.28M7.26M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Mylan financial analysis

China Pharma stock comparison chart provides an easy way to compare the stock price with peers along with details of China Pharma stock price history.
The statement of cash flows can be categorized into the following main sections:

  • China Pharma has cash of $1.94M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the China Pharma stock price.
  • China Pharma decreased its cash from operating activities to $- till 2018 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash from investing stood at a negative value of $-0.03M for CPHI stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $-0.16M for China Pharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For China Pharma Cash Flow

Quarterly Cash Flow Statements For China Pharma Holdings, Inc. Peers

CSL LTD-ADR cash flow, Mylan cash flow, Parnell Pharma cash flow, Pernix Therapeutics cash flow, Sunwin Stevia cash flow